Baxter International Inc.: PharmaVitae Report

Strategic insight into the prospects for Baxter over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales.

Request a Sample for or Inquire before buying the report @ http://www.reportsnreports.com/reports/144099-baxter-international-inc-pharmavitae-report.html

Features and benefits
• Gain insight into Baxter's strategic outlook across the next 6 years
• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source

This analysis examines the historical and forecast performance for Baxter in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Major points covered in Table of Contents of this report include:
• EXECUTIVE SUMMARY
• STRATEGIC INSIGHT
• COMPANY INTRODUCTION
• SALES ANALYSIS
• FINANCIAL ANALYSIS
• PRODUCT ANALYSIS
• APPENDIX
• Tables and Figures

Explore Comprehensive list of more than 40 Tables & Figures available in the report Baxter International Inc.: PharmaVitae Report.

Warner-Chilcott Plc: PharmaVitae Report

This analysis Warner-Chilcott Plc: PharmaVitae Report examines the historical and forecast performance for Warner-Chilcott in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs.

Features and benefits
• Gain insight into Warner-Chilcott's strategic outlook across the next 6 years.
• Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source.

Browse All: Pharmaceuticals Market Research

Table Of Contents
ABOUT THIS REPORT
PharmaVitae Explorer database
Chapter structure
Strategic insight
Company introduction
Sales analysis
Financial analysis
Product analysis
Data sourcing
Analyst consensus

EXECUTIVE SUMMARY
Key findings
Warner Chilcott prescription pharma sales outlook
Warner Chilcott financial outlook
SWOT analysis
Weaknesses
Opportunities
Threats

STRATEGIC INSIGHT
Proctor & Gamble acquisition will shape performance through to 2016
Portfolio has undergone substantial change
Impact of expiries increased by narrower product focus
Patent expiries non-negotiable – pre-erosion cash flow critical to future expansion
P&G acquisition will drive superior operating performance…
and provide platform for further diversification and strategic evolution

COMPANY INTRODUCTION
Background
M&A history